Selecting treatment for hepatocellular carcinoma based on the results of hepatic resection and local ablation therapy

Journal of Surgical Oncology

Volumn 101, Issue 6, 2010, Pages 481-485

  Nanashima, Atsushi ^a   Tobinaga, Syuuichi ^a   Masuda, Junichi ^a   Miyaaki, Hisamitsu ^a   Taura, Naota ^a   Takeshita, Hiroaki ^a   Hidaka, Shigekazu ^a   Sawai, Terumitsu ^a   Nakao, Kazuhiko ^a   Nagayasu, Takeshi ^a  

^a NAGASAKI UNIVERSITY HOSPITAL   (Japan)

Author keywords

Guideline; Hepatic resection; Hepatocellular carcinoma; Local ablation

Indexed keywords

ALBUMIN; BILIRUBIN; PROTHROMBIN;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER SURVIVAL; CANCER THERAPY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; LIVER CELL CARCINOMA; LIVER FUNCTION; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PREOPERATIVE PERIOD; PRIORITY JOURNAL; SURVIVAL RATE; THERMAL ABLATION THERAPY; THROMBOCYTE COUNT; TUMOR RECURRENCE; TUMOR VOLUME;

AGED; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; FEMALE; HEPATECTOMY; HUMANS; LIVER FUNCTION TESTS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL;

EID: 77950828333     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21523     Document Type: Article

References (41)

1. Yamamoto J, Okada S, Shimada K, et al.: Treatment strategy for small hepatocellular carcinoma: Comparison of long-term results after percutaneous ethanol injection therapy and surgical resection. Hepatology 2001;34:707-714.
2. Poon RT, Fan ST: Hepatectomy for hepatocellular carcinoma: Patient selection and postoperative outcome. Liver Transplant 2004;10:39-45.
3. Lau WY, Lai EC: The current role of radiofrequency ablation in the management of hepatocellular carcinoma: A systematic review. Ann Surg 2009;249:20-25.
4. Jansen MC, van Hillegersberg R, Chamuleau RA, et al.: Outcome of regional and local ablative therapies for hepatocellular carcinoma: A collective review. Eur J Surg Oncol 2005;31: 331-347. (Pubitemid 40521297)
5. Makuuchi M, Kokudo N, Arii S, et al.: Development of evidencebased clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan. Hepatol Res 2008;38:37-51. (Pubitemid 350182575)
6. Takasaki T, Kobayashi S, Suzuki S, et al.: Predetermining postoperative hepatic function for hepatectomies. Int Surg 1980; 65:309-313. (Pubitemid 12155191)
7. Miyagawa S, Makuuchi M, Kawasaki S, et al.: Criteria for safe hepatic resection. Am J Surg 1995;169:589-594.
8. Kubota K, Makuuchi M, Kusaka K, et al.: Measurement of liver volume and hepatic functional reserve as a guide to decisionmaking in resection surgery for hepatic tumors. Hepatology 1997; 26:1176-1181. (Pubitemid 27509300)
9. Liver cancer study group of Japan: Clinical findings. In: Makuuchi M, editor. General Rules for the Clinical and Pathological Study of Primary Liver Cancer 2nd English edition. Tokyo: Kanehara Co., Ltd; 2003; 5-28.
10. Nanashima A, Sumida Y, Shindo H, et al.: Thoracoscopy-assisted radiofrequency ablation liver cancer. Report of three cases. Hepatogastroenterology 2007;54:241-245.
11. Nanashima A, Masuda J, Miuma S, et al.: Selection of treatment modality for hepatocellular carcinoma according to the modified Japan Integrated Staging score. World J Gastroenterol 2008;14: 58-63. (Pubitemid 351314327)
12. Yamazaki S, Takayama T: Surgical treatment of hepatocellular carcinoma: Evidence-based outcomes. World J Gastroenterol 2008;14:685-692. (Pubitemid 351325049)
13. Lau WY, Lai EC: Hepatocellular carcinoma: Current management and recent advances. Hepatobiliary Pancreat Dis Int 2008; 7:237-257. (Pubitemid 351895383)
14. Ishizawa T, Hasegawa K, Aoki T, et al.: Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma. Gastroenterology 2008;134:1908-1916. (Pubitemid 351783260)
15. Kokudo N, Makuuchi M: Evidence-based clinical practice guidelines for hepatocellular carcinoma in Japan: The J-HCC guidelines. J Gastroenterol 2009;44:119-121.
16. Kudo M, Okanoue T: Japan Society of Hepatology: Management of hepatocellular carcinoma in Japan: Consensus-based clinical practice manual proposed by the Japan Society of Hepatology. Oncology 2007;72:2-15. (Pubitemid 350256660)
17. Llovet JM, Bruix J: Novel advancements in the management of hepatocellular carcinoma in 2008. J Hepatol 2008;48:S20-S37.
18. Schwartz M, Roayaie S, Uva P: Treatment of HCC in patients awaiting liver transplantation. Am J Transplant 2007;7:1875-1881. (Pubitemid 47037976)
19. Lau WY, Lai EC: The current role of radiofrequency ablation in the management of hepatocellular carcinoma: A systematic review. Ann Surg 2009;249:20-25.
20. Nanashima A, Nakayama T, Sumida Y, et al.: Relationship between microvessel count and post-hepatectomy survival in patients with hepatocellular carcinoma. World J Gastroenterol 2008;14:4915-4922.
21. Todo S, Furukawa H: Japanese Study Group on Organ Transplantation: Living donor liver transplantation for adult patients with hepatocellular carcinoma: Experience in Japan. Ann Surg 2004;240:451-459.
22. Taketomi A, Kayashima H, Soejima Y, et al.: Donor risk in adultto-adult living donor liver transplantation: Impact of left lobe graft. Transplantation 2009;87:445-450.
23. Wong J, Lee KF, Lee PS, et al.: Radiofrequency ablation for 110 malignant liver tumours: Preliminary results on percutaneous and surgical approaches. Asian J Surg 2009;32:13-20.
24. Rust C, Gores GJ: Locoregional management of hepatocellular carcinoma. Surgical and ablation therapies. Clin Liver Dis 2001; 5:161-173.
25. Livraghi T: Guidelines for treatment of liver cancer. Eur J Ultrasound 2001;13:167-176.
26. Crocetti L, Lencioni R: Thermal ablation of hepatocellular carcinoma. Cancer Imaging 2008;8:19-26.
27. Shiina S: Image-guided percutaneous ablation therapies for hepatocellular carcinoma. J Gastroenterol 2009;44:122-131.
28. Rust C, Gores GJ: Locoregional management of hepatocellular carcinoma. Surgical and ablation therapies. Clin Liver Dis 2001; 5:161-173.
29. Buell JF, Thomas MT, Rudich S, et al.: Experience with more than 500 minimally invasive hepatic procedures. Ann Surg 2008;248: 475-486.
30. Ueno S, Sakoda M, Kubo F, et al.: Kagoshima Liver Cancer Study Group: Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria. J Hepatobiliary Pancreat Surg 2009;16:359-366.
31. Kianmanesh R, Ogata S, Paradis V, et al.: Heat-zone effect after surface application of dissecting sealer on the "in situ margin" after tumorectomy for liver tumors. J Am Coll Surg 2008;206: 1122-1128.
32. Liang HH, Chen MS, Peng ZW, et al.: Percutaneous radiofrequency ablation versus repeat hepatectomy for recurrent hepatocellular carcinoma: A retrospective study. Ann Surg Oncol 2008;15:3484-3493.
33. Abu-Hilal M, Primrose JN, Casaril A, et al.: Surgical resection versus radiofrequency ablation in the treatment of small unifocal hepatocellular carcinoma. J Gastrointest Surg 2008;12:1521-1526.
34. Yamakado K, Nakatsuka A, Takaki H, et al.: Early-stage hepatocellular carcinoma: Radiofrequency ablation combined with chemoembolization versus hepatectomy. Radiology 2008; 247:260-266.
35. Guglielmi A, Ruzzenente A, Valdegamberi A, et al.: Radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma in cirrhosis. J Gastrointest Surg 2008; 12:192-198.
36. Maluccio M, Covey AM, Gandhi R, et al.: Comparison of survival rates after bland arterial embolization and ablation versus surgical resection for treating solitary hepatocellular carcinoma up to 7cm. J Vasc Interv Radiol 2005;16:955-961. (Pubitemid 40993518)
37. Vivarelli M, Guglielmi A, Ruzzenente A, et al.: Surgical resection versus percutaneous radiofrequency ablation in the treatment of hepatocellular carcinoma on cirrhotic liver. Ann Surg 2004; 240:102-107. (Pubitemid 38808241)
38. Ueno M, Uchiyama K, Ozawa S, et al.: Prognostic impact of treatment modalities on patients with single nodular recurrence of hepatocellular carcinoma. Surg Today 2009;39:675-681.
39. Nicoli N, Casaril A, Hilal MA, et al.: A case of rapid intrahepatic dissemination of hepatocellular carcinoma after radiofrequency thermal ablation. Am J Surg 2004;188:165-167. (Pubitemid 38916736)
40. Minami Y, Kudo M, Chung H, et al.: Contrast harmonic sonography-guided radiofrequency ablation therapy versus Bmode sonography in hepatocellular carcinoma: Prospective randomized controlled trial. Am J Roentgenol 2007;188:489-494. (Pubitemid 46167751)
41. Taketomi A, Sanefuji K, Soejima Y, et al.: Impact of des-gammacarboxy prothrombin and tumor size on the recurrence of hepatocellular carcinoma after living donor liver transplantation. Transplantation 2009;87:531-537.